News

News & Events

 

January 2020, USA

 

NimbleHeart recognized as one of the leading Cardiac Monitoring companies.

 

Cardiology 2.0, an online Cardiology publication, in their special issue on Cardiac monitoring has recognized NimbleHeart as one of the leading companies that are changing the frontiers of Cardiac Monitoring. Here is the link to the published article in Cardiology 2.0 magazine covering the NimbleHeart story and highlighting the uniqueness of its product offering. 

https://magazine.cardiology2.com/feb2020/nimbleheart_a_treadmill_test_in_a_wrap

 
 
 

January 2020, USA

Physiotrace Smart coverage on NewsWatch show on AMC TV

During their latest technologies show aired on January 27th, 2020 on AMC channel, NewsWatch program covered NimbleHeart Physiotrace Smart with live exercise ECG demonstration on a male with no skin shaving or preparation. 

https://vimeo.com/386337011

 

January 2020, USA

Improving patient enrollment in outpatient Cardiac Rehabilitation

This recent study indicates low patient participation in outpatient Cardiac Rehabilitation, especially by women and minority. NimbleHeart offers a discrete and reusable FDA approved handsfree wearable exercise ECG monitor Physiotrace Smart to enable a true home based Cardiac rehab for such patients.

https://www.dicardiology.com/content/only-1-4-medicare-patients-participate-cardiac-rehabilitation?oly_enc_id=5356I8916523F4J

 

November 2019, San Francisco

NimbleHeart on Space Health Technology radar

NimbleHeart was invited to exhibit at the first Space Health Innovations Conference (SHIC) held at the University of California, San Francisco. There was a great deal of interest for the products’ applications for the upcoming Space Tourism healthcare market. Specific interest was focused on performance, wear-ability, reusability, and the level of practical clinical significance.

NimbleHeart on for Space Health Technology radar

 

September 2019, Portland

NimbleHeart sponsors Innovative Delivery Model for Cardiac Rehabilitation (IDMC)

NimbleHeart was a proud sponsor of the Innovative Delivery Model for Cardiac Rehabilitation exhibit at the Association of Cardiovascular and Pulmonary Rehabilitation’s (aacvpr.org) 34th Annual Conference held in Portland, OR. Home -based, “Hybrid” cardiac rehabilitation is the new frontier of preventive cardiac care. NimbleHeart has the unique technology to facilitate a true remotely monitored Exercise ECG for cardiac rehabilitation centers.

 

May 2019, USA

New era of preventive cardiac care is here

It is not surprising that the vision of remote cardiac care is becoming a reality! Evidence of this trend can be found in the following articles. With new reimbursement guidelines, CMS is also racing along with the new technologies to usher in a new era of preventive cardiac care.  

Primary Prevention of Cardiovascular Disease in Individuals With Type 2 Diabetes: Time for Cardiology to Get Back in the Game

Home-based heart rehab may help patients who can’t get to clinics

 

October 2018, Sunnyvale, California

Bluetooth Low Energy ECG patent granted

USPTO granted NimbleHeart a patent that uniquely identifies the technology to stream live clinical ECG data over Bluetooth Low Energy Interface.

It differentiates NimbleHeart’s technology capabilities from a plethora of ECG snapshot type devices as well as the Bluetooth capable Holter type devices on the market where the data is not displayed live while it is acquired.

 

September 2018, Sunnyvale, California

Move to a new facility to start operations

NimbleHeart team headquarters in Silicon Valley moved to a new R&D and manufacturing capable facility at Miraloma Business Park in Sunnyvale.

 

August 2017, California, USA

FDA clears Physiotrace Smart wearable and reusable device for exercise ECG monitoring

NimbleHeart’s Physiotracetm Smart got FDA’s class II 510(k) clearance to market. The Physiotracetm Smart has a wearable and reusable design that can be wrapped and fastened around the torso. The device uses dry ECG electrodes and embeds an ECG acquisition unit with a Bluetooth Low Energy transmitter. A mobile application controls the data acquisition, displays the status of the device, heart rate and optionally the ECG waveform during a recording session. The mobile App also stores the ECG and the exercise session information and relays it to a cloud server for permanent storage and review by healthcare staff. The Physiotracetm Smart is designed to be used without electrolytic gels and without adhesives that necessitate skin preparation.

 

May 2016, California, USA

TiEcon 2016 announces NimbleHeart Inc. as a 2016 TiE50 Winner

NimbleHeart Inc. is excited to announce that it has been selected as a “2016 TiE50 Winner” for the prestigious TiE50 Technology Awards Program. Winners were announced on Friday, May 6th at the organization’s annual entrepreneurial conference, TiEcon. TiEcon is the world’s largest conference for entrepreneurs and intrapreneurs with loyal participation from top technology companies, leading venture capital firms, and global service providers. Each year, about 5000 attendees from across the world converge upon the Silicon Valley to attend TiEcon.

 

May 2016, Michigan, USA

Steven Keteyian of Henry Ford Hospital joins advisory board

Steven Keteyian, PhD. PhD, FAACVPR the director of Preventive Cardiology at Henry Ford Hospital in Michigan and the board member of American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) has accepted a role on NimbleHeart’s board of advisors.

 

March 2016, Mountain View, USA

Delivered second version of Male and Female ECG harnesses to NASA

NimbleHeart delivered second version of Male and Female ECG harnesses to NASA. The following patch was created by NASA AMES research center team to honor our partnership.

 

 

November 2015, Michigan, USA

Successful completion of pilot clinical study at Henry Ford Hospital

NimbleHeart’s pre-FDA harness was tested on 20 patients at 3 different sites of Henry Ford Hospital Cardiac Rehab program for wearability and patient acceptance.

The study was completed successfully and NimbleHeart received great patient feedback through the same.

“The biggest personal advantage I see is the lack of stickers to deal with. The NimbleHeart harness was faster and quicker to put on and take off. It treated this hairy guy with kid gloves !”

“I liked it so much better. It was not in the way and I didn’t have to contend with the glue from the electrodes that irritate my skin.”

“Can’t wait to replace the old system. (Its more practical and simple and comfortable than old unit by far.)”

 

May 2015, San Diego, USA

Matthew Saval, MS, ACSM-RCEP of Henry Ford Hospital Demonstrates Nimbleheart’s Technology

Matthew Saval, MS, ACSM-RCEP performed a brief live demonstration of NimbleHeart’s innovative, clinical grade one lead dry electrode ECG harness during his presentation on “Integrating Technology into Cardiac Rehabilitation”, during the 62nd annual meeting of American College of Sports Medicine in San Diego, California.

 

May 2015, Boston, USA

NimbleHeart’s Technology & Innovative Solution Presented by Dr. Pramod Deshmukh

NimbleHeart Cofounder and Chief Medical Officer, Dr. Pramod Deshmukh presented NimbleHeart’s technology and innovative solution during 2015 Stanford Biodesign New Arrhythmia Technologies Retreat.

 

April 2015, Mountain View, USA

Successful Completion of 12 lead ECG harnesses to NASA for Monitoring of Crew Members for Health, Performance & Safety

Successfully completed the design of and delivered 12 lead dry electrode based ECG harnesses to NASA. They were tested on male and female subjects to produce clinical grade ECG during supine position, steady state vertical position and during physical exercises such as treadmill walk and biking. These harnesses will be used in the space flight for monitoring of crew members for health, performance and safety.

 

May 2013, India

NimbleHeart Proves Dry Electrode Harness Technology

Clinical study was performed in India with 25 patients with a goal to validate the dry electrode harness based ambulatory ECG technology. 
12 lead ECG treadmill test was compared against NimbleHeart’s single channel modified CB5 lead proof of concept hardware. NimbleHeart device showed comparable ECG results with ST segment changes in the patients.